A systematic analysis of intrinsic regulators for HIV-1 R5 to X4 phenotypic switch

BackgroundHuman immunodeficiency virus isolates most often use chemokine receptor CCR5 or CXCR4 as a co-receptor to enter target cells. During early stages of HIV-1 infection, CCR5-tropic viruses are the predominant species. The CXCR4-tropic viruses may emerge late in infection. Recognition of factors influencing this phenotypic switch may give some hints on the antiviral strategies like anti-HIV/AIDS drugs, gene therapy and vaccines.MethodsTo investigate the mechanism that triggers R5 to X4 phenotypic switch, we performed a systematic sensitivity analysis based on a five-dimensional model with time-varying parameters. We studied the sensitivity of each factor to the CCR5-to-CXCR4 tropism switch and acquired some interesting outcomes beyond expectation.ResultsThe death rate of free virus (dV), rate that uninfected CD4+ Tcells arise from precursors (s) and proliferate as stimulated by antigens (r), and in vivo viral burst size (N) are four robust factors which are constantly observed to have a strong correlation with the evolution of viral phenotype for most patients longitudinally.ConclusionsCrucial factors, which are essential to phenotypic switch and disease progression, are almost the same for different patients at different time points, including the production of both virus and CD4+ Tcells and the decay of virion. It is also worth mentioning that although the sequence of factors sorted by the influence varies between patients, the trends of influences engendered by most factors as disease progresses are similar inter-patients.

[1]  R. V. van Lier,et al.  AIDS pathogenesis: a dynamic interaction between HIV and the immune system. , 1990, Immunology today.

[2]  Gabriella Scarlatti,et al.  Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay , 2001, Journal of Virology.

[3]  Á. McKnight,et al.  Immune escape and tropism of HIV. , 1995, Trends in microbiology.

[4]  John P. Moore,et al.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. , 2004, AIDS research and human retroviruses.

[5]  M. Nakamura,et al.  Mutations of the HIV type 1 V3 loop under selection pressure with neutralizing monoclonal antibody NM-01. , 1997, AIDS research and human retroviruses.

[6]  F Miedema,et al.  T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). , 2000, Blood.

[7]  Silvana Tasca,et al.  Coreceptor Switch in R5-Tropic Simian/Human Immunodeficiency Virus-Infected Macaques , 2007, Journal of Virology.

[8]  R. Swanstrom,et al.  HIV-1 pathogenesis: the virus. , 2012, Cold Spring Harbor perspectives in medicine.

[9]  Carla Kuiken,et al.  Evolution of Syncytium-Inducing and Non-Syncytium-Inducing Biological Virus Clones in Relation to Replication Kinetics during the Course of Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.

[10]  A. Perelson,et al.  Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.

[11]  L. Jones,et al.  HIV-1 Tropism Dynamics and Phylogenetic Analysis from Longitudinal Ultra-Deep Sequencing Data of CCR5- and CXCR4-Using Variants , 2014, PloS one.

[12]  Andrew N. Phillips,et al.  Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.

[13]  Donald E. Mosier,et al.  Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching , 2004, Journal of Virology.

[14]  Marc K Hellerstein,et al.  Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. , 2003, The Journal of clinical investigation.

[15]  I. Keet,et al.  Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.

[16]  Sebastian Bonhoeffer,et al.  The HIV coreceptor switch: a population dynamical perspective. , 2005, Trends in microbiology.

[17]  Xinyu Song,et al.  Properties of stability and Hopf bifurcation for a HIV infection model with time delay , 2010 .

[18]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[19]  Mario Roederer,et al.  Estimating the Infectivity of CCR5-Tropic Simian Immunodeficiency Virus SIVmac251 in the Gut , 2007, Journal of Virology.

[20]  S. Chandrasekhar Stochastic problems in Physics and Astronomy , 1943 .

[21]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[22]  Maria Prins,et al.  Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution. , 2003, AIDS research and human retroviruses.

[23]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[24]  Stephen J. Merrill,et al.  AIDS: Background and the Dynamics of the Decline of Immunocompetence , 2018 .

[25]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[26]  M Roederer,et al.  HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. , 2001, Immunity.

[27]  Monique Nijhuis,et al.  Correlation of coreceptor usage and disease progression , 2012, Current opinion in HIV and AIDS.

[28]  R Hoh,et al.  Factors influencing T-cell turnover in HIV-1-seropositive patients. , 2000, The Journal of clinical investigation.

[29]  Susan Moir,et al.  B cells in HIV infection and disease , 2009, Nature Reviews Immunology.

[30]  Pietro Liò,et al.  Modeling HIV quasispecies evolutionary dynamics , 2007, BMC Evolutionary Biology.

[31]  Alan S. Perelson,et al.  Naïve and Memory Cell Turnover as Drivers of CCR5-to-CXCR4 Tropism Switch in Human Immunodeficiency Virus Type 1: Implications for Therapy , 2006, Journal of Virology.

[32]  A. Garzino-Demo,et al.  The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection , 1996, Nature Medicine.

[33]  R. Kaiser,et al.  Role of HIV‐1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T‐cell count , 1998, Journal of medical virology.

[34]  Michael Loran Dustin,et al.  Costimulation: Building an Immunological Synapse , 1999, Science.

[35]  F Miedema,et al.  Interactions between HIV and the host immune system in the pathogenesis of AIDS. , 1990, AIDS.

[36]  Yao Lu,et al.  In silico Experimentation of Glioma Microenvironment Development and Anti-tumor Therapy , 2012, PLoS Comput. Biol..

[37]  J. McCune,et al.  CCR5- and CXCR4-Utilizing Strains of Human Immunodeficiency Virus Type 1 Exhibit Differential Tropism and Pathogenesis In Vivo , 1998, Journal of Virology.

[38]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[39]  Becca Asquith,et al.  Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.

[40]  Art F. Y. Poon,et al.  Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction , 2015, Scientific Reports.

[41]  Sebastian Bonhoeffer,et al.  HIV coreceptor usage and drug treatment. , 2002, Journal of theoretical biology.

[42]  A. Cann,et al.  A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism , 1993, Journal of virology.